---
name: CMIC HOLDINGS Co., Ltd.
slug: cmicgroup
site: cro
website_domain: cmicgroup.com
summary: CMIC HOLDINGS is a Japanese CRO and CDMO group providing end-to-end pharmaceutical solutions from non-clinical research through manufacturing and post-market support, with recognized expertise in clinical trial management.
tagline: End-to-end pharmaceutical solutions from discovery through commercialization.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-09-21T07:02:28.650Z
services_count: 6
modalities_count: 0
indications_count: 0
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# CMIC HOLDINGS Co., Ltd.

End-to-end pharmaceutical solutions from discovery through commercialization.

Listed on cro.directory.

## Summary

CMIC HOLDINGS is a Japanese CRO and CDMO group providing end-to-end pharmaceutical solutions from non-clinical research through manufacturing and post-market support, with recognized expertise in clinical trial management.

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Regulatory Affairs

## Long description

CMIC HOLDINGS Co., Ltd. is a comprehensive contract research and manufacturing organization serving the global pharmaceutical industry. The group offers integrated solutions spanning the entire pharmaceutical value chain:

**Service Areas:**
- Non-Clinical CRO services
- Clinical Research Organization (CRO) capabilities
- Contract Development and Manufacturing Organization (CDMO) services
- Sales and Marketing Organization (SMO) support
- Contract Sales Organization (CSO) services
- Consulting and regulatory affairs

**Recognition:**
The organization was recognized as a "Winner" in the 2026 Fierce Outsourcing Awards for Clinical Trial Management, demonstrating industry-leading capabilities in clinical operations.

**Scope:**
CMIC HOLDINGS operates as a holding company with multiple specialized subsidiaries addressing diverse pharmaceutical development and commercialization needs. The group actively participates in major industry conferences including BioJapan and DIA Japan Annual Meeting, reflecting its commitment to innovation and professional engagement in the life sciences sector.

## Related companies

- [Evanjo CRO](/companies/evanjo-cro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/evanjo-cro)
- [SanaClis](/companies/sanaclis) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/sanaclis)
- [PCM Trials](/companies/pcmtrials) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/pcmtrials)
- [Krescent Medical Research](/companies/krescentmr) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/krescentmr)
- [PharPoint Research](/companies/pharpoint) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/pharpoint)
- [ProRelix Research](/companies/prorelixresearch) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/prorelixresearch)
- [ERGOMED Group](/companies/ergomed) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/ergomed)
- [JSS Medical Research](/companies/jssresearch) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/jssresearch)

_Profile last updated: 2026-09-21T07:02:28.650Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.